HILLSIDE, N.J., Aug. 30, 2007 (PRIME NEWSWIRE) -- Integrated BioPharma, Inc. (Nasdaq:INBP) announced that the Securities and Exchange Commission (SEC) has approved the Company’s application to withdraw its registration statement on Form S-3, which had been declared effective by the SEC on July 11, 2007. The withdrawal of the registration statement was requested because the selling stockholders listed therein do not at this time plan to sell securities of the Company as contemplated by the registration statement. No securities were sold pursuant to the prospectus included in the registration statement.
